FUNCTIONALIZED N-METHYL-N-[4-(1-PYRROLIDINYL)-2-BUTYNYL] AMIDES AS SELECTIVE MUSCARINIC AGENTS

被引：0
|
作者：
BRADBURY, BJ
JACOBSON, KA
BAUMGOLD, J
机构：
[1] NIDDK,CHEM LAB,BETHESDA,MD 20892
[2] NINCDS,MOLEC & CELLULAR NEUROBIOL LAB,MEMBRANE BIOCHEM SECT,BETHESDA,MD 20892
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 1989年 / 198卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
引用
收藏
页码：6 / MEDI
相关论文
共 50 条
  • [21] Irreversible binding of N-methyl-N-[(1S)-1-(4-isothiocyanatophenyl)-2-(1-pyrrolidinyl)ethyl-3,4-dichlorophenylacetamide to the cloned rat kappa opioid receptor
    Chen, CG
    Yin, JL
    Li, JG
    Xue, JC
    Weerawarna, SA
    Nelson, WL
    LiuChen, LY
    LIFE SCIENCES, 1997, 61 (08) : 787 - 794
  • [22] Use of 4-[(2-bromoethyl)methyl-amino]-2-butynyl N-(3-chlorophenyl)carbamate (BR 384), to study allosteric interactions at M2 muscarinic receptor
    Suga, Hinako
    Ehlert, Frederick James
    FASEB JOURNAL, 2008, 22
  • [23] TERTIARY 2-HALOETHYLAMINE DERIVATIVES OF THE MUSCARINIC AGENT MCN-A-343, [4-[[N-(3-CHLOROPHENYL)CARBAMOYL]OXY]-2-BUTYNYL]TRIMETHYLAMMONIUM CHLORIDE
    RINGDAHL, B
    MELLIN, C
    EHLERT, FJ
    ROCH, M
    RICE, KM
    JENDEN, DJ
    JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (01) : 281 - 286
  • [24] STRUCTURE ACTIVITY STUDIES RELATED TO 2-(3,4-DICHLOROPHENYL)-N-METHYL-N-[2-(1-PYRROLIDINYL)-1-SUBSTITUTED-ETHYL]ACETAMIDES - A NOVEL SERIES OF POTENT AND SELECTIVE KAPPA-OPIOID AGONISTS
    BARLOW, JJ
    BLACKBURN, TP
    COSTELLO, GF
    JAMES, R
    LECOUNT, DJ
    MAIN, BG
    PEARCE, RJ
    RUSSELL, K
    SHAW, JS
    JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (11) : 3150 - 3158
  • [25] [4-[[N-(3-Chlorophenyl)carbamoyl]oxy]-2-butynyl]-trimethylammonium (McN-A-343)-related compounds.: Effect of the butynyl chain inclusion into an aromatic unit on the potency for muscarinic receptors
    Tumiatti, V
    Angeli, P
    Andrisano, V
    Bolognesi, ML
    Cavalli, A
    Marucci, G
    Minarini, A
    Recanatini, M
    Rosini, M
    Melchiorre, C
    BIOORGANIC & MEDICINAL CHEMISTRY, 2000, 8 (04) : 681 - 689
  • [26] SOME N-METHYL-N-(4-CHLOROPHTHALAZINYL-1)-HYDRAZONES
    BUZYKIN, BI
    BYSTRYKH, NN
    STOLYAROV, AP
    FLEGONTOV, SA
    KITAYEV, YP
    KHIMIYA GETEROTSIKLICHESKIKH SOEDINENII, 1978, (04): : 530 - 536
  • [27] Two useful methods for the preparation of (R)- and (S)-N-methyl-1-phenyl-2-(1-pyrrolidinyl)ethanamine
    deSousa, SE
    OBrien, P
    Poumellec, P
    TETRAHEDRON-ASYMMETRY, 1997, 8 (15) : 2613 - 2618
  • [28] 1-{[N-methyl-N-(4-methylphenyl)amino]methyl}-ferrocene
    Wang, HX
    Li, YJ
    Wu, HF
    Zhou, HC
    Geng, FY
    Gao, RQ
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2005, 61 : M2322 - M2323
  • [29] STRUCTURE OF ETHYL 2-CHLORO-4-METHYL-6-(1-PYRROLIDINYL)BENZOATE
    SCHLICKSUPP, L
    QUINCY, DA
    NATALE, NR
    ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS, 1989, 45 : 1561 - 1563
  • [30] SYNTHESIS AND PHARMACOLOGICAL PROPERTIES OF N-[4-(1-AZETIDINYL)-2-BUTYNYL]-2-PYRROLIDONE, A HIGHLY POTENT OXOTREMORINE-LIKE AGENT
    RESUL, B
    LEWANDER, T
    ZETTERSTROM, T
    RINGDAHL, B
    MUHIELDEEN, Z
    DAHLBOM, R
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 1980, 32 (06) : 439 - 440
12345